A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma

Giesen, Nicola; Chatterjee, Manik; Scheid, Christof; Poos, Alexandra M.; Besemer, Britta; Miah, Kaya; Benner, Axel; Becker, Nicole; Moehler, Thomas; Metzler, Ivana; Khandanpour, Cyrus; Seidel-Glaetzer, Andrea; Trautmann-Grill, Karolin; Kortuem, K. Martin; Mueller-Tidow, Carsten; Mechtersheimer, Gunhild; Goeppert, Benjamin; Stenzinger, Albrecht; Weinhold, Niels; Goldschmidt, Hartmut; Weisel, Katja; Raab, Marc S.

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma

Author:

Giesen, Nicola; Chatterjee, Manik; Scheid, Christof; Poos, Alexandra M.; Besemer, Britta; Miah, Kaya; Benner, Axel; Becker, Nicole; Moehler, Thomas; Metzler, Ivana; Khandanpour, Cyrus; Seidel-Glaetzer, Andrea; Trautmann-Grill, Karolin; Kortuem, K. Martin; Mueller-Tidow, Carsten; Mechtersheimer, Gunhild; Goeppert, Benjamin; Stenzinger, Albrecht; Weinhold, Niels; Goldschmidt, Hartmut; Weisel, Katja; Raab, Marc S.

Tübinger Autor(en):

Besemer, Britta

Published in:

Blood (2023), Bd. 141, H. 14, S. 1685-1690

Verlagsangabe:

Amer Soc Hematology

Language:

English

Full text:

http://dx.doi.org/10.1182/blood.2022017789

ISSN:

0006-4971